Cited by 148Barrier Structure and Function StudiesAcute Ischemic Stroke ManagementNeurological Disorders and Treatments

Focusing on claudin-5: A promising candidate in the regulation of BBB to treat ischemic stroke

Lv, Jianjun, Hu, Wei, Yang, Zhi, Li, Tian, Jiang, Shuai, Ma, Zhiqiang, Chen, Fulin, Yang, Yang·2018·Progress in Neurobiology

Abstract

Claudin-5 is a tight junction (TJ) protein in the blood-brain barrier (BBB) that has recently attracted increased attention. Numerous studies have demonstrated that claudin-5 regulates the integrity and permeability of the BBB. Increased claudin-5 expression plays a neuroprotective role in neurological diseases, particularly in cerebral ischemic stroke. Moreover, claudin-5 might be a potential marker for early hemorrhagic transformation detection in ischemic stroke. In light of the distinctive effects of claudin-5 on the nervous system, we present the elaborate network of roles that claudin-5 plays in ischemic stroke. In this review, we first introduce basic knowledge regarding the BBB and the claudin family, the characterization and regulation of claudin-5, and association between claudin-5 and other TJ proteins. Subsequently, we describe BBB dysfunction and neuron-specific drivers of pathogenesis of ischemic stroke, including inflammatory disequilibrium and oxidative stress. Furthermore, we summarize promising ischemic stroke treatments that target the BBB via claudin-5, including modified rt-PA therapy, pharmacotherapy, hormone treatment, receptor-targeted therapy, gene therapy, and physical therapy. This review highlights recent advances and provides a comprehensive summary of claudin-5 in the regulation of the BBB and may be helpful for drug design and clinical therapy for treatment of ischemic stroke.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2017.12.001

Cites

177 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 179 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Lv, J., Hu, W., Yang, Z., Li, T., Jiang, S., Ma, Z., Chen, F., & Yang, Y.
Affiliations
  • Northwest University (CN)
  • Air Force Medical University (CN)
  • Tang Du Hospital (CN)
Corresponding author
Yang, Yang
Venue
Progress in Neurobiology
Publisher
Elsevier BV
Published
2018-02
Volume
161
Pages
79-96
ISSN
0301-0082 (ISSN-L)
OpenAlex
W2771763619
Cited by
148
References
179
Citations by year
2026: 7 · 2025: 17 · 2024: 16 · 2023: 13 · 2022: 17 · 2021: 26 · 2020: 23 · 2019: 16 · 2018: 13
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81500263)
  • China Postdoctoral Science Foundation (2016T90973, 2015M572681)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
Keywords
claudin-5, blood-brain barrier, ischemic stroke, tight junction proteins, blood-brain barrier permeability, hemorrhagic transformation, neuroprotection, oxidative stress, neuroinflammation, gene therapy, hormone therapy, receptor-targeted therapy, physiotherapy
MeSH terms
Animals, Blood-Brain Barrier, Brain Ischemia, Humans, Tissue Plasminogen Activator, Tight Junctions, Stroke, Claudin-5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review